Triodos Investment Management Bv Cooper Companies, Inc. Transaction History

Triodos Investment Management Bv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$306.88 - $380.0 $61,376 - $76,000	200 Added 5.0%	4,200 $1.59 Million
Q3 2023 Nov 07, 2023	BUY	$315.92 - $397.36 $126,368 - $158,944	400 Added 11.11%	4,000 $1.27 Million
Q2 2023 Aug 09, 2023	BUY	$346.15 - $392.09 $77,883 - $88,220	225 Added 6.67%	3,600 $1.38 Million
Q4 2022 Feb 08, 2023	BUY	$248.67 - $334.17 $279,753 - $375,941	1,125 Added 50.0%	3,375 $1.12 Million
Q3 2022 Nov 09, 2022	BUY	$263.81 - $337.27 $593,572 - $758,857	2,250 New	2,250 $594,000

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Triodos Investment Management Bv, based on Form 13F filings with the SEC.

Stay updated on Triodos Investment Management Bv with notifications on news.